@article{houot:hal-00744066,
TITLE = {Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS.},
AUTHOR = {Houot, Roch and Le Gouill, Steven and Ojeda Uribe, Mario and Mounier, C. and Courby, St{\'e}phane and Dartigeas, Caroline and Bouabdallah, K. and Alexis Vigier, M. and Moles, Marie Pierre and Tournilhac, Olivier and Arakelyan, Nina and Rodon, Philippe and El Yamani, Abderrazak and Sutton, L. and Fornecker, L. and Assouline, D. and Harousseau, Jean-Luc and Maisonneuve, Herv{\'e} and Caulet-Maugendre, Sylvie and Gressin, R{\'e}mi},
URL = {https://hal.science/hal-00744066},
JOURNAL = {Annals of Oncology},
PUBLISHER = {Elsevier},
VOLUME = {23},
NUMBER = {6},
PAGES = {1555-61},
YEAR = {2012},
MONTH = Jun, DOI = {10.1093/annonc/mdr450},
KEYWORDS = {bortezomib ; elderly ; lymphoma ; mantle cell ; rituximab},
HAL_ID = {hal-00744066},
HAL_VERSION = {v1},
}